Drugs / PICEID
PICEID
also known as
Polydatin · (e)-piceid · (e)-polydatin · Resveratrol 3-.beta.-mono-d-glucoside · Trans-piceid · Trans-polydatin
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01780129 | Feb 2013 → Sep 2014 | — | Neptunus Pharmaceuticals Inc. | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02372903 | Oct 2013 → Aug 2015 | chronic pain syndrome, endometriosis | University of Cagliari | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PICEID | ChEMBL registry synonym — accepted as the source's own label CHEMBL142652 ↗ |
| Known as | (e)-piceid | ChEMBL registry synonym — accepted as the source's own label CHEMBL142652 ↗ |
| Known as | (e)-polydatin | ChEMBL registry synonym — accepted as the source's own label CHEMBL142652 ↗ |
| Known as | Polydatin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01780129 ↗ |
| Known as | Resveratrol 3-.beta.-mono-d-glucoside | ChEMBL registry synonym — accepted as the source's own label CHEMBL142652 ↗ |
| Known as | Trans-piceid | ChEMBL registry synonym — accepted as the source's own label CHEMBL142652 ↗ |
| Known as | Trans-polydatin | ChEMBL registry synonym — accepted as the source's own label CHEMBL142652 ↗ |
| Modality | Small molecule | — CHEMBL142652 ↗ |
| Route | Intravenous | “administer as i.v. infusion over 2 hours” NCT01780129 ↗ |